zebularine

Zebularine (4-Deoxyuridine) is a DNA methylation inhibitor. Acts as a transition state analog inhibitor of cytidine deaminase by binding to the active size as covalent hydrates. It also inhibits cytidine deaminase (Ki: 2 μM, in a cell-free assay).

N4-(n-Palmitoyl)-4'-azido-2'-deoxy-2'-fluoro-arabinocytidine is a cytidine nucleoside analog with potential anti-metabolic and anti-tumor activities due to its mechanism of inhibiting DNA methyltransferases (such as Zebularine) [1].

3,5'-Bis(O-t-butyldimethylsilyl)-2'-O-methyl-5-methyl cytidine, a cytidine analog, inhibits DNA methyltransferases (e.g., Zebularine) and exhibits potential anti-metabolic and anti-tumor activities [1].

N4-(3,3,3-Trifluoropropanoyl)cytidine, a cytidine analog, inhibits DNA methyltransferases (such as Zebularine0), and demonstrates potential anti-metabolic and anti-tumor activities [1].

N4-Benzoyl-3'-O-DMT-2'-O-(2-methoxyethyl)-5-methylcytidine is a cytidine analog that inhibits DNA methyltransferases (such as Zebularine).

N4-Methylcytidine (Nsc518744) is a cytidine nucleoside analog that belongs to a class of compounds capable of inhibiting DNA methyltransferases, similar to other cytidine analogs such as Zebularine.N4-Methylcytidine demonstrates potential anti-metabolic and antitumor activities, making it a valuable research tool for studying epigenetic regulation, DNA methylation dynamics, and cancer-associated metabolic reprogramming.